Clinical Trial Update: Envafolimab Combined With Chemotherapy in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Envafolimab in combination with chemotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma is ong…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Envafolimab (envafolimab)

Snippet

Sponsor: Tao Jiang | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN